Literature DB >> 12431982

Mechanisms of regulation of phospholipase D1 by protein kinase Calpha.

Tianhui Hu1, John H Exton.   

Abstract

It has been suggested that protein-protein interaction is important for protein kinase C (PKC) alpha to activate phospholipase D1 (PLD1). To determine the one or more sites on PKCalpha that are involved in binding to PLD1, fragments containing the regulatory domain, catalytic domain, and C1-C3 domain of PKCalpha were constructed and shown to be functional, but they all failed to bind and activate PLD1 in vivo and in vitro. A C-terminal 23-amino acid (aa) deletion mutant of PKCalpha was also found to be inactive. To define the binding/activation site(s) in the C terminus of PKCalpha, 1- to 11-aa deletion mutants were made in this terminus. Deletion of up to 9 aa did not alter the ability of PKCalpha to bind and activate PLDl, whereas a 10-aa deletion was inactive. The residue at position 10 was Phe(663). Mutations of this residue (F663D and F663A) caused loss of binding, activation, and phosphorylation of PLD1, indicating that Phe(663) is essential for these activities. Time course experiments showed that the activation of PLD1 by PMA was much faster than its phosphorylation, and its activity decreased as phosphorylation increased with time. Staurosporine, a PKC inhibitor, completely inhibited PLD1 phosphorylation in response to 4beta-phorbol 12-myristate 13-acetate PMA and blocked the later decrease in PLD activity. The same results were found with the D481E mutant of PKCalpha, which is unable to phosphorylate PLD1. These results indicate that neither the regulatory nor catalytic domains of PKCalpha alone can bind to or activate PLD1 and that a residue in the C terminus of PKCalpha (Phe(663)) is required for these effects. The initial activation of PLD1 by PMA is highly correlated with the binding of PKCalpha. Although PKCalpha can phosphorylate PLD1, this is a relatively slow process and is associated with inactivation of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431982     DOI: 10.1074/jbc.M210093200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

2.  Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.

Authors:  Mohamad El Osta; Mengling Liu; Mohamad Adada; Can E Senkal; Jolanta Idkowiak-Baldys; Lina M Obeid; Christopher J Clarke; Yusuf A Hannun
Journal:  FASEB J       Date:  2013-10-11       Impact factor: 5.191

Review 3.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils.

Authors:  Laura J Norton; Qifeng Zhang; Khalid M Saqib; Heinrich Schrewe; Karol Macura; Karen E Anderson; Craig W Lindsley; H Alex Brown; Simon A Rudge; Michael J O Wakelam
Journal:  J Cell Sci       Date:  2011-05-24       Impact factor: 5.285

5.  Mechanism of membrane redistribution of protein kinase C by its ATP-competitive inhibitors.

Authors:  Hideyuki Takahashi; Hideo Namiki
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

6.  An effector domain mutant of Arf6 implicates phospholipase D in endosomal membrane recycling.

Authors:  Olivera A Jovanovic; Fraser D Brown; Julie G Donaldson
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

7.  Phospholipase D1, but not D2, regulates protein secretion via Rho/ROCK in a Ras/Raf-independent, MEK-dependent manner in rat lacrimal gland.

Authors:  Robin R Hodges; Erin Guilbert; Marie A Shatos; Viswanathan Natarajan; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

8.  Functional interaction of PkcA and PldB regulate aggregation and development in Dictyostelium discoideum.

Authors:  Sean Singh; Wasima Mohamed; Annelie Aguessy; Ella Dyett; Shriraj Shah; Mohammedasad Khan; Ramamurthy Baskar; Derrick Brazill
Journal:  Cell Signal       Date:  2017-02-28       Impact factor: 4.315

Review 9.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

10.  Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Authors:  Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.